Overview

A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
To compare the analgesic efficacy and safety of ABT-652 administered twice daily (BID) to placebo in subjects with osteoarthritis (OA) of the knee.
Phase:
Phase 2
Details
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Treatments:
Naproxen